In 2020, Celik et al. [63] compared the HE4 protein expression observed in 23 cases of serous carcinoma of the uterus with that observed in 29 cases of serous carcinoma of the ovary. This evidence concerns the gene WFDC2 and ovarian serous adenocarcinoma.